There are 2949 resources available
1688P - Outcome of older cancer patients infected with COVID-19 at Gustave Roussy Cancer Center
Presenter: Mathilde Hauchecorne
Session: E-Poster Display
Resources:
Abstract
1689P - The appropriateness of invasive ventilation in COVID-19 positive cancer patients: The hardest decision for oncologists
Presenter: Michele Ghidini
Session: E-Poster Display
Resources:
Abstract
1690P - Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19
Presenter: Rebecca Lee
Session: E-Poster Display
Resources:
Abstract
1691P - Evaluation of practice variation for cancer patients care in a French cancer center during the COVID-19 outbreak
Presenter: Delphine Borchiellini
Session: E-Poster Display
Resources:
Abstract
1692P - SARS-CoV-2 RNA testing in cancer patients treated at a Department of Medical Oncology in Vienna, Austria
Presenter: Anna Sophie Berghoff
Session: E-Poster Display
Resources:
Abstract
1693P - Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic
Presenter: Cristina Gurizzan
Session: E-Poster Display
Resources:
Abstract
1694P - Discovery of circulating biomarkers in COVID-19 patients undergoing anti-IL6R immunotherapy
Presenter: Jean-Marie Michot
Session: E-Poster Display
Resources:
Abstract
1714P - Change of circulating pro-inflammatory markers between pre-COVID-19 condition and COVID-19 diagnosis predicts early death in cancer patients: The FLARE score
Presenter: Elia Seguí
Session: E-Poster Display
Resources:
Abstract
1715P - Plinabulin (Plin) is a more favorable option for the prevention of chemotherapy induced neutropenia (CIN) than pegfilgrastim (Peg) during the COVID-19 pandemic
Presenter: Douglas Blayney
Session: E-Poster Display
Resources:
Abstract
1716P - Vigil plasmid (VP), a dual bi-shRNA-furin/GMCSF construct from cancer to SARS-CoV-2
Presenter: Christopher Jay
Session: E-Poster Display
Resources:
Abstract